March 09, 2026

​​​​​​​PsA Treatment Options Expand

Phase 3 POETYK trial results support FDA approval of deucravacitinib for adults with active PsA.

Conexiant

March 06, 2026

RA-ILD: Tracking Function and CT

Conventional monitoring markers do not change before deaths in this predominantly mild cohort.

Conexiant

March 05, 2026

Did Medicine Lose Its Aura Before AI?

From the clinical gaze to electronic health records, a JAMA essay traces the long technological arc that set the stage for AI in medicine.

Conexiant

March 05, 2026

Anti-CD146 Linked to Silica in Systemic Sclerosis

Comparative analysis across exposed workers, cancer controls, and healthy donors supports specificity.

Conexiant

March 04, 2026

Exercise in Osteoarthritis: Does It Help?

Overview data on exercise therapy in osteoarthritis question its universal promotion

Conexiant

March 04, 2026

Spatial Proteomics Reveals Early Osteoarthritis Changes 

MALDI-MSI maps bone-derived protein changes that extend beyond visible cartilage damage 

The Analytical Scientist

March 02, 2026

Machine Learning May Help Refine Fracture Risk Prediction

"Machine learning should be used to identify postmenopausal women at increased risk of fractures."

Conexiant

February 26, 2026

‘You Aren’t Trapped’: Hundreds of US Nurses Choose Canada

Workforce shortages on both sides of the border add urgency.

KFF Health News

February 25, 2026

Upadacitinib and Pain in RA, PsA

Mediation analysis suggests direct and indirect effects on pain reduction in rheumatoid and psoriatic arthritis.

Conexiant

February 25, 2026

Medical Oddities: For the Birds—and the Brain

Birds for brains, blackout laughs, anti-aging tea, thin air, muscle memory—and torn marriages, all with a clinical touch this week.

Conexiant